Used in pharmaceutical research as a potent inhibitor of specific kinase enzymes involved in cancer cell proliferation. Shows promise in targeted therapies for solid tumors due to its ability to modulate signaling pathways that control cell growth and survival. Its structure allows for high selectivity, reducing off-target effects in preclinical studies. Currently investigated for antitumor activity, particularly in lung and breast cancer models. Also serves as a scaffold for developing new analogs with improved bioavailability and potency.